# Meditoxin® Treatment in Patients With Post Stroke Upper Limb Spasticity

> **NCT02757404** · PHASE4 · COMPLETED · sponsor: **Medy-Tox** · enrollment: 59 (actual)

## Conditions studied

- Muscle Spasticity

## Interventions

- **DRUG:** Ultrasonography guidance injection of Meditoxin®.
- **DRUG:** Electrical stimulation guidance injection of Meditoxin®.
- **DRUG:** Manual needle placement injection of Meditoxin®.

## Key facts

- **NCT ID:** NCT02757404
- **Lead sponsor:** Medy-Tox
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-30
- **Primary completion:** 2016-08-16
- **Final completion:** 2016-08-16
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2019-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02757404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02757404, "Meditoxin® Treatment in Patients With Post Stroke Upper Limb Spasticity". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02757404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*